Dynavax Technologies Corporation (NASDAQ:DVAX)

Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
DVAX Weekly Chart

Old Forum Content for DVAX

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • woodman: $DVAX - haven't looked at this chart in some time. Too bad.
  • rjw225: $DVAX which makes a Hepatitis B vaccine and an adjuvant for COVID vaccines, is going higher. Could it be an earnings run? It is to report on August 3.
  • scottrades: Some Earnings after the close today: $AMD $F $SBUX $ET $SMCI $LTHM $CZR $PAYC $LUMN $MTCH $SPG $CLX $CHK $OKE $YUMC $WU $PRTS $DVAX $TRVG $SAR $PRU $ARWR $BAND $NRDS $SRPT $CWH $OHI $PACB $DENN $BGFV $MUSA $EQX $HLF $INSP $SPT $ANDE $APLE $WELL $AFG $CRK $AKR $EXPI $CLW $HRZN $MTW $FRSH $LSI $EXR $ATGE $UNM
  • woodman: $DVAX - One I've been holding (a core position wit some trading around it) . It moved out of its base in early Nov (up through 200d resistance). Mid November, it pulled back to and bounced off the 200d (new support) which was my trigger to add. It's moving back up through the 8dEMA today and now through the 20d just above. I think this has more to go.
  • MongosPawn: @woodman $DVAX Picked up a starter on the bounce today. Got away from me yesterday.
  • swingbound: @woodman $DVAX The 38.2% ~ 12.65 is the pivot higher .
  • woodman: $DVAX moving up off 200d.
  • DAN: ...
    $DVAX -- Pullback bounce. Testing both moving averages. Phase 2 pullback complete? Alert $12.50
    $FMC -- Lots of setups now. Clean breakout on twice avg volume. Alert $131
    $REGN -- Close to breaking out. Massive volume spike today. Watch this ...
  • woodman: $DVAX - pullback to the 200d, with the 50d just below but moving up. Look for bounce potentially this week.
  • pperlroth: @woodman $DVAX been adding on this pullback!
  • woodman: $DVAX - a good bit of buying in the last 40 minutes into the close to regain the high of the day.
  • swingbound: $DVAX Daily view with WEEKLY markers : Green is approximately the 20SMAW in perfect retest also the ~38.2% Retracement
  • woodman: $DVAX continues its ascent out of base.
  • Crodmm: @woodman $DVAX took a starter last week when you mentioned it at 12.60. Hope this turns out to be another $ELF. Thanks again.
  • sgiseller: $DVAX Small starter position
  • woodman: $DVAX looks like it wants to continue higher out of base. (I'm still in this.)
  • sierramp: @woodman $DVAX Thanks. Interesting chart, some very good numbers. Took a starter.
  • woodman: @sierramp $DVAX - Yes, they had a nice report.
  • woodman: $DVAX - Keep an eye on this. Looks poised to move higher out of a little consolidation. I added yesterday, and am waiting now before adding more.
  • swingbound: $DVAX This is a new day of the same DAILY view with WEEKLY markers : The fuscia line ~ 20SMAW . We are closing in a Bullish hammer holstered after dipping into the 8EMAD .
  • woodman: $DVAX flagging following last week's breakout. Recent report was nice: Dynavax Technologies (DVAX) reported 3rd Quarter September 2022 earnings of $0.43 per share on revenue of $167.7 million. The consensus earnings estimate was $0.33 per share on revenue of $149.3 million. Revenue grew 54.9% on a year-over-year basis.
  • swingbound: @woodman $DVAX `~ 12.65 is a tradable pivot 38.2% Retracement overhead for potential entry ... the next FIB range ( next two ) encompasses the heavy red daily declines leading down to this pivot and long cup base .
  • woodman: $DVAX - breaking out from flag after retest of prior breakout from long base. I posted earlier today (and in prior days) on this and its great earnings/revs report recently. I've been holding a position and added on this b/o. Lots of room above.
  • swingbound: $DVAX Daily view with Weekly markers . Fuscia is ~ 20SMAW . It has taken the pivot ~ 38.2% Retracement
  • woodman: @swingbound $DVAX - Optimistically, I can see this getting to $15, then reevaluate.
  • swingbound: @woodman $DVAX That would be a nice run , sounds perfect .
  • woodman: $DVAX pullback to test Friday's earnings related breakout. 12.17 was the high of the prior 2+ month range/base from which it broke-out.
  • 1993dean: @DAN $SPY $DIA $UNH $MDY $IWM $QQQ $T2108 $T2107 $WBA $JPM $SGML $LLY $TBT $TNX $XLE $BTU $HAL $APA $HES $LNG $BITO $DVAX $METC $CEIX $AMR $ARCH $ARLP
  • pperlroth: $DVAX nice move long from below
  • woodman: @pperlroth $DVAX - Blast from my past. Thanks for posting this.
  • woodman: @pperlroth $DVAX Earnings move. I like this move out of long base and now up above all the moving averages. Dynavax Technologies (DVAX) reported 3rd Quarter September 2022 earnings of $0.43 per share on revenue of $167.7 million. The consensus earnings estimate was $0.33 per share on revenue of $149.3 million. Revenue grew 54.9% on a year-over-year basis.
  • swingbound: $DVAX WEEKLY view S1 50SMAW , S2 8EMAW . R1 20SMAW , R2 38.2 % Retracement . Its a significant pivot to overcome ( so also presumably tradable , IMHO ) . np
  • DAN: ...
    $DVAX -- This could work.

    Coal:
    iX1050
    $BTU -- Watch for $29 breakout. Alert $29
    $METC -- Needs to clear the 200 DMA.
    $CEIX -- Forming a base in the 60’s.
    $AMR -- This is looking really good. Lots of possibilities
    $ARCH -- Nothing here. ...
  • woodman: $DVAX - after about a 135% move from the May bottom (multi-bottom level) to a peak about a week ago, this one made a hard move down back to through the 50d and now back the 200d where, at least for the moment, is finding some support. It's on my radar again.
  • woodman: @wineinquirer $LABU $XBI $MRNA $NVAX $BNTX - I sold $DVAX this morning. Will look to buy it back.
  • woodman: @mharps $SGMO $ALEC $LABU - I held $DVAX through earnings, and added this morning. It's rocking. Wish I had $BLUE - that's having quite a day as well. .
  • woodman: $DVAX hit a homerun. Up ~11% in the after. Dynavax Technologies (DVAX) reported 2nd Quarter June 2022 earnings of $0.86 per share on revenue of $256.5 million. The consensus earnings estimate was $0.22 per share on revenue of $150.6 million. Revenue grew 386.0% on a year-over-year basis.
  • Wykeman: $DVAX Nice vol breaking above 15. NP
  • woodman: @joelsg1 $MRNA - #Virus stocks looking decent. See also $BNTX $DVAX $VIR. But this is true of the #biotech space more broadly as well.
  • woodman: @woodman $MRNA $BNTX $DVAX $VIR #Virus #biotech - And $NVAX for virus stocks.
  • woodman: @scottrades $NVAX #CovidIsOver - a lot #Virus stocks doing well. And monkeypox is getting more news. $DVAX $VIR $MRNA $BTNX
  • AdrenalineTrade: $DVAX short from 10.15
  • woodman: @Motorman $PFE - Now I know why my $DVAX is down. PFE is already slated to make nearly $40 billion this year on the vaccine. Now this pill. They have a gold making machine at HQ.
  • BellaVino: @woodman $PFE $DVAX It's all about the $ with a pill or a shot (or both yay!) for every ill.
  • woodman: $DVAX, fyi Shares of Dynavax Technologies (NASDAQ:DVAX) are poised to move this week due to two important events. Tomorrow, the CDC's Advisory Committee on Immunization Practices is set to discuss a universal adult hepatitis B vaccine recommendation. Dynavax could benefit with a vote in the affirmative as the company markets the Heplisav-B vaccine. Heplisav-B had $136.1M in revenue in 1H 2021, and the company says the vaccine has a U.S. market opportunity of up to $600M annually. On Thursday, Dynavax reports Q3 2021 earnings. In Q2, the company beat on both EPS and revenue. Dynavax has momentum given that many companies are using its CpG 1018 adjuvant, including in COVID-19 vaccines. Most recently, Valneva (VALN -3.4%) posted positive results on its COVID vaccine candidate, boosting both stocks. Dynavax shares also surged in September after partner Clover Biopharmaceuticals reported positive data on its COVID vaccine.
  • Momentariness: $DVAX bouncing nicely off VWAP, starting a position
  • woodman: @Momentariness $DVAX - welcome aboard. :-)
  • Carpe_Diem: $DVAX - I really like it here. The weekly chart looks good and it has some strength rhrn.
  • woodman: @Carpe_Diem $DVAX - I'm still in this one from lower level . I like this weekly pennant, with narrowing channel and rising channel support, starting to pinch, as it does the work on low volume.
  • randyhagan: $INMD and $DVAX getting volume
  • issues: My vaccination stocks seem to be pulling out of steep dive: $NVAX $REGN $BNTX. It's curious that $DVAX is on the IBD 50...? I used Dan's method of using stops instead of selling them so I can still make something back. The government is forcing vaccinations so I thought these would be good this fall... what am I missing???
  • NickSingh: @issues $NVAX $REGN $BNTX $DVAX $NVAX has to go back up, I want it to.:)
  • woodman: $SB $DDOG $PAVM $AVTR $ASAN $TMO $ACTG $FOX/FOXA $DVAX $HZNP $TSLA $CRDL $CROX $KEY $CFG- here are several that have the moving averages aligned properly (8dEMA>21dEMA>50dSMA>200dSMA) and have been on a roll generally, though not all are necessarily at a good buy spot. Just for ideas.
  • Pokersmith: @woodman $SB $DDOG $PAVM $AVTR $ASAN $TMO $ACTG $FOX $DVAX $HZNP $TSLA $CRDL $CROX $KEY $CFG Good post 👍
  • woodman: @Pokersmith $SB $DDOG $PAVM $AVTR $ASAN $TMO $ACTG $FOX $DVAX $HZNP $TSLA $CRDL $CROX $KEY $CFG - And I think they're all weaker now than when I posted. These are rough seas right now. Best to keep the boat well tethered to the dock.
  • woodman: $DVAX has remained strong. Short term Right shoulder test of inv. h and s neckline.
  • bRobert: @pperlroth $NVAX $MRNA $BNTX $DVAX I like the chart but np $25 target 1 $30 potential Pullbacks to add You had one yesterday close to the 20d Stop just below
  • pperlroth: @bRobert $NVAX $MRNA $BNTX got a position in all. Did you add $DVAX to the mix as well?
  • Motorman: $DVAX Up 35% on news of Clover vaccine candidate.
  • woodman: @Motorman $DVAX - I was waiting for this, but in the end decided I didn't want to roll the dice. Glad for the news, though. I'm fairly tapped out on binary decision $$ at the moment as I await another in a very spec stock.
  • woodman: $DVAX may be a buy at this level. I don't like the gap down last week, but seems to be stabilizing as it finds support at the old short term breakout top on 8/13. Could grind here for a while, though. Still, I wouldn't count this one out. It was a helluva move from that breakout on 8/3 to 9/1.
  • Motorman: $DVAX Down on news UK cancelled vaccine deal with $VALN who $DVAX supplies. NP in either.
  • woodman: @Motorman $DVAX $VALN - fwiw.... https://www.fool.com/investing/2021/09/13/why-dynavax-technologies-stock-is-sinking-today/
  • Motorman: @woodman $DVAX $VALN Are you adding?
  • woodman: @Motorman $DVAX $VALN - Not just yet. I don't have much and haven't done anything today. Previously, I had lightened the load on the way up given the crazy move. This is a breakdown on the daily, but it stopped dropping at the old swift-move "top" on 8/13 (ending the phase one breakout move). That old resistance could be new support, but right now I'm watching it.
  • Motorman: @woodman $DVAX $VALN Good for you, getting out with strong move.
  • Wykeman: $DVAX Expected pb. Has had a massive run.
  • Wykeman: $DVAX Wow keeps going..trying to hold some.
  • woodman: $DVAX - phase 3 still going. Six months of sideways created a lot of steam for a breakout. But quite extended now. Needs a pullback.
  • bRobert: @woodman $DVAX Kudos. Your Many posts have kept us on top of this $20+
  • woodman: @bRobert $DVAX - blind pig (me) finds nut. :-)
  • bRobert: @woodman $DVAX I have donated to the the blind mice foundation. I'll look into the pigs
  • bRobert: @woodman $DVAX I gave to Habitat for Humanity to rebuild the Pigs home after blown down
  • woodman: @bRobert $DVAX - can't skimp on bricks. Straw doesn't cut it.
  • woodman: $DVAX continues to kill it.
  • Wykeman: @woodman $DVAX yes, I did sell some into closing ramp. I was looking for $15
  • woodman: $DVAX - must be some news.
  • teacher5: @woodman $DVAX COVID-19 vaccine rollout in Taiwan.
  • woodman: @teacher5 $DVAX - here's what I saw. https://markets.businessinsider.com/news/stocks/powered-by-dynavax-adjuvant-medigen-covid-19-vaccine-launched-in-taiwan-1030752874
  • woodman: @teacher5 $DVAX - and some chatter indicating great progress by $DVAX with their CpG 1018 adjuvant is now being used in Heplisav and Medigen's C19 vax. Medigen's vax is a license from NIH. Dynavax adjuvant should experience more licensing opportunities. (Not my words, just what I saw elsewhere.)
  • teacher5: @woodman $DVAX Thanks!
  • woodman: $DVAX pullback to test breakout. Successful so far.
  • woodman: $DVAX - raise stops.
  • rjw225: $dvax I have been in this stock for several months and wish to keep it for awhile. Can some members suggest an options strategy to preserve the gains from the past month?
  • woodman: $DVAX still running.
  • Wykeman: $DVAX 20% short NH looks like 15 could be in play
  • woodman: $DVAX moving out of 6-month box.
  • woodman: $DVAX continues to move out of squeeze moving back to top of range about a buck higher.
  • woodman: $DVAX - also mentioned this yesterday as in a squeeze and to keep an eye on. Popping today.
  • Louis Berg: $BEAM, $DVAX, $FYBR, $HMHC, $HUBS, $KLIC, $LSPD, $MELI, $NTLA, $OPRX, $RYI, $TRI, $SQ, $TTGT, $UHAL, $WCC
  • woodman: $DVAX - pretty tight squeeze for this one, relatively speaking. Six-month move sideways. Resistance over this period is around the same level as the highs of 2020. I think it's worth keeping an eye on. That said, I have not checked on binary event dates/catalysts for it.
  • woodman: $DVAX looks like it may be up to something here. Very long handle to cup. About 20% to get back up to handle high.
  • woodman: $DVAX building a base.
  • rjw225: $DVAX is on the move.
  • rjw225: $DVAX and $AUPH -- anybody in these biotechs? Any opinions from more experienced players will be appreciated.
  • Motorman: @rjw225 $DVAX $AUPH Yes in $AUPH, cut position in half at 12 to contain losses, then it went to 10, now it reversed. Up against 200 day now from underside and 50 week.
  • rjw225: $DVAX is perking up again. Anybody else in this vaccine maker?
  • rjw225: $dvax is on the move. Provides adjuvants for COVID vaccines and has HEPLISAV-B approved in the US and Europe.
  • rjw225: $DVAX anybody in this vaccine maker? It is making an adjuvant (explained very well by @cmdrjake in the past) for COVID vaccines and its vaccine for Hepatitis B just got approved in Europe.
  • rjw225: $DVAX question to @DAN, @SCOTTRADES and @CDR JAKE: is this another anti-short seller raid? If so, how high do you think it may go? The stock is up by 45% and volume is insane. But I have been in this stock b/c of the upcoming EU approval of its HEPLISAV-B vaccine and their efforts on COVID vaccine in India. Will be much obliged for the pearls of wisdom from the cognoscenti.
Visit the Trading Forum to join in the discussion.
Stock Price $12.41
Change 0.00%
Volume 376,839

Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases.

Request Video of DVAX
Already a member? Sign in here.
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!